MBOBRA

This brand name is authorized in Nigeria.

Active ingredients

The drug MBOBRA contains one active pharmaceutical ingredient (API):

1	Dexamethasone UNII 7S5I7G3JQL - DEXAMETHASONE
	Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.
	Read more about Dexamethasone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-2249	Tablet	MBOBRA TABLETS TAB 0.5 mg 10 X 10	155 RNW-PP-274712 MBOBRA TABLETS DEXAMETHSAONE BP 0.5MG DEXAMETHASONE TABLETS BP 0.5MG. EXCIPIENTS Q.S B4-2249 Drugs Imported Products 10X10 Prescription Only Medicine (POM) 5/19/2023 IBU PHARM NIG LTD, LABIRAN STREET, IKENNE OGUN STATE 8184435083 ibupharm240@gmail.com M/S IMPULSE PHARMA PVT LTD, J-201, 202/I TARAPUR M.I.D.C, BOISAR, THANE-401506, MAHARSHTRA, INDIA., India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB02	Dexamethasone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-2249